Jonathan W. Simons, M.D. Director, Winship Cancer Institute of Emory University and Professor, Hematology & Oncology Emory University School of Medicine Winship Cancer Institute 1365-C Clifton Road NE Suite 4014 Atlanta, GA 30322 Phone: 404-778-5871 |  Fax:  404-778-5048 jsimons@prostatecancerfoundation.org B.S. Princeton University, 1980 M.D. Johns Hopkins University School of Medicine, 1984 Research Interests Genomic pharmacology and pharmacogenetics of prostate cancer and personalized oncology translational research in cancer nanotechnologies for human cancer Jonathan W. Simons, M.D. is the Director of the Winship Cancer Institute of Emory University and Professor of Hematology & Oncology, he also holds a joint appointment with the School of Materials Science and Engineering. Dr. Simons was named Director of the Winship Cancer Institute in February, 2000.  A highly acclaimed investigator in translational cancer research, he was Director of the Genetic Pharmacology Program and Cancer Gene Therapy Laboratory at The Johns Hopkins Sidney Kimmel Cancer Center and Johns Hopkins University School of Medicine.  Dr. Simons is internationally recognized as a widely published and cited leader in molecular oncology of prostate cancer. He is the first investigator to successfully use human gene therapy to create clinically measurable immune responses against metastatic prostate cancer using vaccines.    Young investigators in Dr. Simons’ laboratory have identified four new genetic targets and mechanisms for genetic therapy approaches to the treatment of prostate cancer and other common human cancers. All four approaches have now entered early human clinical trials in the United States.  Dr. Simons is a B.S. graduate of Princeton University (1980) and received his M.D. degree from The Johns Hopkins University School of Medicine (1984). Before entering medical school he was a Rotary International Postgraduate Fellow in the Humanities at the University of Kent, Canterbury, England, and a Nuffield Foundation Fellow in the Department of Biochemistry, University of Cambridge. Dr. Simons completed his residency in internal medicine at the Massachusetts General Hospital, Harvard MedicalSchool. He began his career in cancer research as a fellow in the Laboratory of Molecular Genetics of Dr. Bert Vogelstein at The Johns Hopkins Oncology Center. Return to top